BIOADHESIVE OPHTHALMICS

Bioadhesive Ophthalmics is a developer of a pharmaceutical platform that aims to transform ophthalmology by relieving patients from the burden of their eye diseases. The company's pharmaceutical technology includes a mucoadhesive ocular hydrogel insert that releases a therapeutic molecule medicinal substances to the eye continuously over a period of a week, thus enhancing the impact of treatment, enabling the eye patients to get ease from the complexity of frequent eye drop application by generating a continuous and controlled sustained hydrogel release. It was founded in Orsay, Ile-de-France, France by Jean Garrec and Jean Cuiné in 2020.